A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. - Wikidata - wikimedia - TriplyDB

A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.

A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.

http://www.wikidata.org/entity/Q30541785

about

Therapeutic Approach to Adult Fibrotic Lung Diseases Cell-based therapy in lung regenerative medicine The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review Update on therapeutic management of idiopathic pulmonary fibrosis Enzymatic and non-enzymatic isolation systems for adipose tissue-derived cells: current state of the art.Amnion Epithelial Cells Promote Lung Repair via Lipoxin A4 Clinical observation of umbilical cord mesenchymal stem cell treatment of severe idiopathic pulmonary fibrosis: A case report.Serious adverse events of cell therapy for respiratory diseases: a systematic review and meta-analysis An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.MSC therapy attenuates obliterative bronchiolitis after murine bone marrow transplant Muse cells, newly found non-tumorigenic pluripotent stem cells, reside in human mesenchymal tissues.Mesenchymal stem cells correct inappropriate epithelial-mesenchyme relation in pulmonary fibrosis using stanniocalcin-1.Pilot safety study of intrabronchial instillation of bone marrow-derived mononuclear cells in patients with silicosis Development of a System and Method for Automated Isolation of Stromal Vascular Fraction from Adipose Tissue Lipoaspirate.Adult Lung Spheroid Cells Contain Progenitor Cells and Mediate Regeneration in Rodents With Bleomycin-Induced Pulmonary Fibrosis.From bench to bedside: use of human adipose-derived stem cells.Adipose-Derived Stem Cells Alleviate Radiation-Induced Muscular Fibrosis by Suppressing the Expression of TGF-β1.Are They Really Stem Cells? Scrutinizing the Identity of Cells and the Quality of Reporting in the Use of Adipose Tissue-Derived Stem Cells.Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice.Autologous mesenchymal stem cell therapy for progressive supranuclear palsy: translation into a phase I controlled, randomized clinical study.Adipose-Derived Mesenchymal Stem Cells for Treatment of Airway Injuries in A Patient after Long-Term Exposure to Sulfur Mustard.iPSC-derived mesenchymal stem cells exert SCF-dependent recovery of cigarette smoke-induced apoptosis/proliferation imbalance in airway cells.Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives.Methods and procedures in adipose stem cells: state of the art and perspective for translation medicine.Diagnosis and management of interstitial lung disease.Fluorine-19 Labeling of Stromal Vascular Fraction Cells for Clinical Imaging Applications.Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis.Stem Cell Therapy: Current Applications and Potential for Urology.Mesenchymal Stromal Cells in Animal Bleomycin Pulmonary Fibrosis Models: A Systematic Review.Concise Review: A Safety Assessment of Adipose-Derived Cell Therapy in Clinical Trials: A Systematic Review of Reported Adverse Events.TNF-α-induced NF-κB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis.Comparison of intraoperative procedures for isolation of clinical grade stromal vascular fraction for regenerative purposes: a systematic review.Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial.New treatment directions for IPF: current status of ongoing and upcoming clinical trials.Cardiopulmonary and histological characterization of an acute rat lung injury model demonstrating safety of mesenchymal stromal cell infusion.MSC from fetal and adult lungs possess lung-specific properties compared to bone marrow-derived MSC Multipotent mesenchymal stem cells in lung fibrosis.Human Adipose-derived Mesenchymal Stem Cells Attenuate Early Stage of Bleomycin Induced Pulmonary Fibrosis: Comparison with Pirfenidone.Cell-Based Therapies for Tissue Fibrosis.Mesenchymal stromal stem cell therapy in advanced interstitial lung disease - Anaphylaxis and short-term follow-up.

P2860

Q26741569-307A6299-943C-45E5-B4FB-89939E6B35F3 Q26852285-E8B25823-8D7D-437E-9397-F3E187D02F16 Q26992007-15C5037A-CE7E-4485-BA09-C96BC85C4E8C Q28083944-3B159AC1-62AC-4DC1-9EC0-89784C4BE7AA Q30401607-7B280800-F144-4A02-80D2-B12EACD1531F Q33722569-AE52E0EA-C701-40B7-A4F4-AD052956AB14 Q33724205-6448CDF2-2309-4309-BC13-558E5E80A9CC Q33728374-809BF6E8-3418-4082-9500-25B9C58E67C7 Q33783282-A736470B-8DBE-40F5-9132-38199D049067 Q34278561-00706998-28F4-4720-9FA7-FCD64637B685 Q34400554-7A5F34D3-BDDC-4930-8F55-1A6E16897C68 Q35153085-819EB387-2CC4-4B75-ABDA-31B881C5D304 Q35658853-47BD22FE-F49E-4C11-B4F5-1CBA5EAD6832 Q35763624-08950375-4037-4B00-BFE5-12D015737D59 Q36212666-C877F354-48AB-479D-BD7F-CCFFFE3DA899 Q36257063-FCB909B3-62BF-4822-86EC-51BE8AE242BE Q36328943-24E11BF2-E1A9-420A-B5A8-3ECB223DECC9 Q36427302-6CD2F50F-9339-4FCA-B9F8-2A6EF4BE6CE6 Q37420861-F55F93B2-207D-49E0-91B5-8ABEBDF6F005 Q37550552-B457161F-4C61-4B34-B35A-75267788D518 Q37590912-E202B913-F059-434F-A1FF-257899771153 Q37604374-1106F934-18C0-4EE5-B680-D5332823724D Q37668859-2A29A318-1A1E-4F88-8C66-1596DCE802F8 Q38258028-B6B29BEE-BFBC-4BE1-8206-72F30248BB7B Q38288028-81C54BC7-28A5-440E-983C-F6B683E71F2F Q38401259-1CF8A1C8-4AC6-413C-9136-C21A6089C956 Q38432028-9911004C-F53A-4156-902A-C17054A16AC4 Q38589422-21703039-510B-41BE-86F3-5E6D6640B90D Q38614634-DAE7986B-DAA3-40E7-90FE-DF0C442319D0 Q38655379-15AEFB60-DA28-4897-9BBF-F659453C78A3 Q38668289-E47AD817-3BD7-4AC8-BF8D-4F7C5457FF99 Q39085445-65C2391D-22CE-45AD-95BB-D4D6AF5324FB Q39150558-3B566B9A-78D7-422E-9724-0577172988B1 Q39330304-821164FC-4DEB-4CB4-8719-19AF446A5E05 Q39618827-1A293589-A475-4DD3-8C1D-5A9C8C0F35F4 Q39629527-9B0640F2-E7C1-4E5B-A2B9-5C687ADF2CC5 Q41474873-BDC62C69-3C84-4BD1-82A5-712AC6775E2C Q42254883-16233D9A-9851-4616-B700-CE051E2FC8D0 Q42369905-385434DF-CB45-41A3-992F-04597A4B195F Q43237224-CD1641D0-28D1-42A5-8CD4-01F46CD8CD9B

P2860

A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.

http://www.wikidata.org/entity/Q30541785

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

A prospective, non-randomized, ...... idiopathic pulmonary fibrosis.

@ast

A prospective, non-randomized, ...... idiopathic pulmonary fibrosis.

@en

type

label

A prospective, non-randomized, ...... idiopathic pulmonary fibrosis.

@ast

A prospective, non-randomized, ...... idiopathic pulmonary fibrosis.

@en

prefLabel

A prospective, non-randomized, ...... idiopathic pulmonary fibrosis.

@ast

A prospective, non-randomized, ...... idiopathic pulmonary fibrosis.

@en

P1433

Q30541785-7440F08B-97D0-4651-87CF-BB8CD5C23300

P1476

Q30541785-4113A2FD-8FE8-4365-ADD1-429F4F960FE5

P2093

Q30541785-040156DA-834D-4AD3-B2D3-ED8022B2DACF

Q30541785-096209DC-5557-4C54-8D00-3A83B94C99E6

Q30541785-1BFF3B2F-A4AE-42DE-B248-AF7A46A15C33

Q30541785-1ECCFD32-3B99-47CD-A1AA-B7359FC636D0

Q30541785-25834594-6344-47A4-9E89-8045C5FFADA4

Q30541785-4C1AE0DA-9D7A-44CC-BF65-DDAF59395174

Q30541785-578AF1FB-F097-4833-9970-79F11DBA7B38

Q30541785-7E9B70FE-5776-4D47-AE7E-0847C7552C39

Q30541785-9442B065-E701-4F2D-834C-CAB2FB92CA51

Q30541785-9DF7FF81-AFBA-4EF7-A694-F5AA96F7DA09

P2860

Q30541785-066E81C6-9B81-46D2-AA95-EB3AD4B75B10

Q30541785-0A6B1B34-43FB-4575-90F5-490E6546A7EC

Q30541785-104E375D-3DD1-4FB1-810F-16B4F73A346B

Q30541785-160C851D-D74F-43A5-9E18-FBDFF86F011D

Q30541785-167EF42F-A4A6-4DCD-9B5D-57A5F594B0F3

Q30541785-1800F3A7-B04D-400C-9FA8-1A9E69FDE02F

Q30541785-21881513-4CEE-436E-8EEA-C9FDD2B3CFDA

Q30541785-22FBEF64-8050-4B2D-9D8D-96938688A774

Q30541785-25191A4D-D72D-43A8-8ABB-B65E89508380

Q30541785-2577A846-A038-4F69-95C0-A05FE31D9FC7

P2888

Q30541785-E58F2E9B-00F6-4892-AEB1-8FF42CC4C471

P304

Q30541785-328C9741-CC6B-4DA2-A5E7-FC313FF0D059

P31

Q30541785-50BE9B49-8433-4E1E-ABD8-9F1C8B8D360D

P356

Q30541785-B3850F2D-915B-4FFF-BB06-C91A960CF79D

P478

Q30541785-976D37A6-9476-4329-8432-7C16453CCD29

P577

Q30541785-E46B768B-DC0F-4ED6-A0D7-C18F08776706

P5875

Q30541785-DAC0CD1D-CD43-4866-BBAA-D6213A046582

P6179

Q30541785-D25F3871-3F79-4409-ABA2-2116296B8D69

P698

Q30541785-D7D6D718-877C-4D39-A76F-BC2230D89540

P921

Q30541785-40E904C4-C97A-4A5A-A8C8-C52E176F6E2F

Q30541785-5C6E4242-9755-444B-8555-707016143B32

Q30541785-840114B3-097E-4BA6-8E13-C04F75F97F20

P932

Q30541785-F94B70D0-71B2-4A86-A11C-84B17DBF8CFC

P356

1479-5876-11-171

P1433

Journal of Translational Medicine

P1476

A prospective, non-randomized, ...... idiopathic pulmonary fibrosis.

@en

P2093

Anastasia Oikonomou

http://www.w3.org/2001/XMLSchema#string

Antonis Antoniadis

http://www.w3.org/2001/XMLSchema#string

Argyris Tzouvelekis

http://www.w3.org/2001/XMLSchema#string

Athanassios Zissimopoulos

http://www.w3.org/2001/XMLSchema#string

Brian Dardzinski

http://www.w3.org/2001/XMLSchema#string

Demosthenes Bouros

http://www.w3.org/2001/XMLSchema#string

Dimitrios Gritzalis

http://www.w3.org/2001/XMLSchema#string

Evangelos Bouros

http://www.w3.org/2001/XMLSchema#string

George Koliakos

http://www.w3.org/2001/XMLSchema#string

George Kolios

http://www.w3.org/2001/XMLSchema#string

P2860

Stem Cell Therapy in Chronic Obstructive Pulmonary Disease. Seeking the Prometheus Effect

Stem Cell Treatment for Chronic Lung Diseases

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

Human adipose tissue is a source of multipotent stem cells

Stem cells and cell therapies in lung biology and lung diseases

Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis.

Lasers, stem cells, and COPD.

Incidence and prevalence of idiopathic pulmonary fibrosis.

P2888

1479-5876-11-171

P304

171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-11-171

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

249646665

http://www.w3.org/2001/XMLSchema#string

P6179

1031190099

http://www.w3.org/2001/XMLSchema#string

P698

23855653

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

3722100

http://www.w3.org/2001/XMLSchema#string